https://doi.org/10.4081/hmr.v2i7.436

The impact of new drugs in the high dose strategy

Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
Published: June 8, 2009
Abstract Views: 155
PDF: 134
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M Attal
support@pagepress.org
During the past ten years, major advances in the treatment have improved the outlook in myeloma. The antitumor activity of thalidomide, bortezomib and lenalidomide has been discovered. In elderly patients, the combination of these new drugs with conventional chemotherapy has been reported to induce a high response rate and to improve overall survival. In young patients, these new drugs have been evaluated to improve the outcome of high dose therapy supported with autologous transplantation. This abstract will focus on the impact of these new drugs in the transplantation setting: 1) during induction therapy, 2) combined with the high dose regimen, and 3) used as maintenance therapy post transplantation.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Attal, M. (2009). The impact of new drugs in the high dose strategy. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.436
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).